STOCK TITAN

Lemaitre Vasculr - LMAT STOCK NEWS

Welcome to our dedicated page for Lemaitre Vasculr news (Ticker: LMAT), a resource for investors and traders seeking the latest updates and insights on Lemaitre Vasculr stock.

Overview of LeMaitre Vascular

LeMaitre Vascular (LMAT) is a specialized medical device company that designs, manufactures, and markets a comprehensive range of disposable and implantable vascular devices. Focusing on the treatment of peripheral vascular disease, the company develops innovative solutions used during open vascular surgeries. Its products cover key anatomical areas including the carotid arteries, lower and upper extremities, and the aorta. With a strong presence in the United States, LeMaitre Vascular has established itself as a trusted partner for vascular surgeons by providing devices that address complex circulatory challenges.

Product Portfolio and Applications

LeMaitre Vascular's extensive product portfolio includes device categories such as vascular grafts, angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular patches, and vessel closure systems. Each product undergoes rigorous design and testing processes to ensure it meets the highest standards of quality and reliability. The company’s dedication to innovation is reflected in its continuous improvements in manufacturing efficiencies and device performance, ensuring that medical professionals have access to reliable tools for both diagnostic and therapeutic procedures.

Business Operations and Market Position

The company operates within a highly specialized segment of the medical technology industry, where precision and regulatory compliance are paramount. LeMaitre Vascular generates revenue primarily through the sale of its devices, which are engineered to address specific surgical requirements. While its diverse product range caters mainly to the needs of vascular surgeons, the company also leverages its extensive distribution network to maintain a strong presence across multiple geographic regions. Its focus on manufacturing excellence and cost-effective production processes supports consistent product availability and quality, further solidifying its position in the competitive medtech landscape.

Quality, Compliance, and Industry Expertise

Quality assurance is central to LeMaitre Vascular’s operational philosophy. The company adheres to stringent regulatory guidelines and quality control measures, ensuring that each device meets both clinical and safety standards. Its commitment to excellence is reinforced by a history of robust manufacturing practices and a culture that prioritizes continuous enhancement. Through rigorous training, advanced testing methodologies, and a dedication to innovation, LeMaitre Vascular fosters trust and reliability among healthcare professionals.

Competitive Landscape and Differentiation

In a competitive medical devices sector, LeMaitre Vascular distinguishes itself through its focused expertise in peripheral vascular disease. The company’s dedication to developing specialized devices for open vascular surgery provides it with a competitive advantage. Its ability to combine innovative design with operational efficiency allows for effective cost control while maintaining high product performance. By addressing specific clinical needs, LeMaitre Vascular stands apart from competitors who may offer broader, less specialized product lines.

Understanding the Customer and Clinical Impact

The core customers of LeMaitre Vascular are vascular surgeons who require reliable, high-performance devices in the operating room. The company’s products are integral to procedures that significantly impact patient outcomes, addressing a condition that affects millions worldwide. By blending deep clinical insights with advanced technological innovation, LeMaitre Vascular not only supports critical surgical interventions but also contributes to the advancement of vascular treatment worldwide.

Strategic Information Hierarchy

This overview is structured to provide a clear, logical flow of information: from a broad description of the company’s core business to detailed insights into its product portfolio, operational procedures, competitive positioning, and quality management practices. Each section is designed to deliver insight through expert terminology and precise explanations, ensuring readers gain a comprehensive understanding of LeMaitre Vascular’s role in the medical devices industry.

Rhea-AI Summary
LeMaitre Vascular, Inc. (LMAT) is set to announce its fourth quarter 2023 financial results on February 27, 2024, with a conference call scheduled to discuss the results, business highlights, and company outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.24%
Tags
-
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) CFO to Present at 26th Annual Needham Growth Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.36%
Tags
conferences
-
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) will be participating in three upcoming investor conferences in November. The conferences include Jefferies London Healthcare Conference on November 14 in London, UK, where the Chief Financial Officer will present at 11:00 AM GMT. Stifel's 2023 Healthcare Conference will also take place on November 14 in New York City, with the President presenting at 1:50 PM ET. Lastly, the Piper Sandler 35th Annual Healthcare Conference will be held on November 29 in New York City, where the President will present at 2:10 PM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
News
Rhea-AI Summary
LeMaitre (Nasdaq:LMAT) reported Q3 2023 results with sales of $47.4mm, a 21% increase from Q3 2022. Gross margin increased to 65.0%. Operating income grew by 49% to $9.2mm. Net income was $7.5mm, a 38% increase. The company announced a $0.14/share quarterly dividend. Q4 2023 guidance projects sales of $48.0mm - $50.0mm and operating income of $9.4mm - $10.7mm.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
-
Rhea-AI Summary
LeMaitre Vascular to release Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
-
Rhea-AI Summary
LeMaitre Vascular, Inc. to present at Cantor Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
conferences
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
conferences

FAQ

What is the current stock price of Lemaitre Vasculr (LMAT)?

The current stock price of Lemaitre Vasculr (LMAT) is $84.67 as of April 16, 2025.

What is the market cap of Lemaitre Vasculr (LMAT)?

The market cap of Lemaitre Vasculr (LMAT) is approximately 1.9B.

What is the core business of LeMaitre Vascular?

LeMaitre Vascular designs, manufactures, and markets a range of disposable and implantable devices used in vascular surgery, focusing on treatments for peripheral vascular disease.

Which patient condition does LeMaitre Vascular address?

The company focuses on peripheral vascular disease, providing medical devices that aid in the surgical treatment of circulatory conditions affecting areas such as the carotid, lower extremities, upper extremities, and aorta.

Who are the primary customers of LeMaitre Vascular?

The company primarily serves vascular surgeons and medical facilities, offering specialized devices that are critical during open vascular surgical procedures.

What types of products does LeMaitre Vascular offer?

Their product lineup includes vascular grafts, angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular patches, and vessel closure systems, all designed for various vascular applications.

How does LeMaitre Vascular differentiate itself from competitors?

By focusing on a specialized segment within the medtech industry and emphasizing high-quality, innovative products for open vascular surgery, LeMaitre Vascular offers targeted solutions that meet specific clinical needs.

In which markets does LeMaitre Vascular primarily operate?

While maintaining a strong presence in the United States, LeMaitre Vascular also serves a global market, collaborating with a network that spans several key geographic regions.

How does the company ensure its products meet quality standards?

LeMaitre Vascular applies rigorous quality control measures and adheres to stringent regulatory guidelines, ensuring that every device is safe, reliable, and effective in clinical settings.

What role does innovation play in LeMaitre Vascular's operations?

Innovation is central to the company’s approach, continuously enhancing product design, manufacturing efficiency, and operational effectiveness to support surgeons and improve patient outcomes.
Lemaitre Vasculr

Nasdaq:LMAT

LMAT Rankings

LMAT Stock Data

1.86B
20.56M
8.85%
95.59%
5.09%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON